GENEVA, Feb. 3 -- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (HofgartenstraBe 880539 Munchen) filed a patent application (PCT/EP2024/070941) for "A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE" on Jul 23, 2024. With publication no. WO/2025/021835, the details related to the patent application was published on Jan 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZERIAL, Marino (c/o Max-Planck-Institut fur molekulare Zellbiologie und Genetik,PfotenhauerstraBe 10801307 Dresden), NADLER, Christina (c/o Max-Planck-Institut fur molekulare Zellbiologie und Genetik...